RA study I at 24 weeks, RA study II at 26 weeks, and RA study III at 24 and 52 weeks b 40 mg Humira administered every other week c MTX = methotrexate **p < 0.01, Humira versus placebo
studio AR I a 24 settimane, studio AR II a 26 settimane, e studio AR III a 24 e 52 settimane b 40 mg di Humira somministrato ogni due settimane c MTX = metotressato **p < 0,01, Humira versus placebo